Literature DB >> 12096254

Higher prevalence of obstructive airway disease in patients with thoracic or abdominal aortic aneurysm.

Fumio Sakamaki1, Hideo Oya, Noritoshi Nagaya, Shingo Kyotani, Toru Satoh, Norifumi Nakanishi.   

Abstract

BACKGROUND AND AIM: The risk factors of aortic aneurysm (AA) are comparable with those described for chronic obstructive pulmonary disease. This study was performed to determine whether patients with AA have a higher than average prevalence of obstructive airway disease.
METHODS: We performed pulmonary function tests in 240 consecutive patients (182 men and 58 women; age, 70 +/- 10 years) with thoracic or abdominal AA. The results were compared with those in individuals without obvious cardiovascular disease (control) and in patients with coronary artery disease who were matched for age, gender, smoking status, and other atherosclerotic risk factors.
RESULTS: Patients in the AA group had a lower forced expiratory volume in 1 second/forced vital capacity (%) and carbon monoxide diffusing capacity (%/predicted value) than did the control group (P <.01). The proportion of patients with airway obstruction, defined as forced expiratory volume in 1 second/forced vital capacity of 70% or less, was higher in the AA group (100/240; 42%) than in the control (51/223; 23%) and coronary artery disease (43/238; 18%) groups. Multiple logistic regression analysis results revealed that the presence of an AA and male gender were associated with a higher risk of airway obstruction (odds ratio, 2.928; 95% CI, 1.722 to 4.979; and odds ratio, 1.622; 95% CI, 1.055 to 2.493, respectively).
CONCLUSION: These data suggest that AA may be a risk factor indicative of the presence of chronic obstructive pulmonary disease. A higher prevalence of depressed pulmonary function should be suspected as a preoperative risk in presence of thoracic or abdominal AA as compared with other types of cardiovascular disorders.

Entities:  

Mesh:

Year:  2002        PMID: 12096254     DOI: 10.1067/mva.2002.123087

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Prevalence and risk factors of aortic aneurysm in patients with chronic obstructive pulmonary disease.

Authors:  Katsutoshi Ando; Norihiro Kaneko; Tokuhide Doi; Masahiro Aoshima; Kazuhisa Takahashi
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 2.  No association of chronic obstructive pulmonary disease with abdominal aortic aneurysm growth.

Authors:  Hisato Takagi; Takuya Umemoto
Journal:  Heart Vessels       Date:  2016-01-21       Impact factor: 2.037

3.  Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.

Authors:  Yasuhiko Kubota; Aaron R Folsom; Kunihiro Matsushita; David Couper; Weihong Tang
Journal:  Atherosclerosis       Date:  2017-10-13       Impact factor: 5.162

4.  Screening of COPD patients for abdominal aortic aneurysm.

Authors:  Ingo H Flessenkaemper; Robert Loddenkemper; Stephanie Roll; Kathrin Enke-Melzer; Henrik Wurps; Torsten T Bauer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-10

5.  Extracellular matrix defects in aneurysmal Fibulin-4 mice predispose to lung emphysema.

Authors:  Natasja W M Ramnath; Koen M van de Luijtgaarden; Ingrid van der Pluijm; Menno van Nimwegen; Paula M van Heijningen; Sigrid M A Swagemakers; Bibi S van Thiel; Ruziedi Y Ridwan; Nicole van Vliet; Marcel Vermeij; Luuk J A C Hawinkels; Anne de Munck; Oleh Dzyubachyk; Erik Meijering; Peter van der Spek; Robbert Rottier; Hiromi Yanagisawa; Rudi W Hendriks; Roland Kanaar; Ellen V Rouwet; Alex Kleinjan; Jeroen Essers
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

6.  The TAGA Study: A Study of Factors Determining Aortic Diameter in Families at High Risk of Abdominal Aortic Aneurysm Reveal Two New Candidate Genes.

Authors:  Olga Peypoch; Ferran Paüls-Vergés; Miquel Vázquez-Santiago; Jaime Dilme; Jose Romero; Jordi Giner; Vicente Plaza; Jose Roman Escudero; Jose Manuel Soria; Mercedes Camacho; Maria Sabater-Lleal
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.